Pharma & Biotech

MiMedx Group Inc. is capturing significant market attention following a prominent upgrade to "Strong Buy" from Wall Street Zen. This...

Biogen finds itself in a curious position, delivering impressive third-quarter 2025 results that simultaneously impressed market analysts and disappointed investors....

The biotechnology sector has identified a compelling new prospect as Anixa Biosciences gains attention for its innovative approaches to cancer...

All eyes are on KORU Medical Systems as the medical technology firm prepares to release its third-quarter 2025 financial results...

The upcoming quarterly report from Heron Therapeutics represents a pivotal moment for the biotechnology firm's stock performance. Scheduled for release...

Investors are closely watching Mirum Pharmaceuticals as the biopharmaceutical company prepares to release its third-quarter 2025 financial results this Tuesday....

Investors in Catalyst Pharmaceuticals are bracing for a significant market-moving event this week as the biopharma company prepares to release...

This week represents a critical juncture for Altimmune as the biopharmaceutical company prepares to release its third-quarter 2025 financial results...

The German biotech firm CureVac has delivered a remarkable financial performance that has captivated both investors and market analysts. After...

BioNxt Solutions, a Canadian life sciences company, has reached a significant regulatory milestone that could strengthen its intellectual property portfolio....